A Phase 3, Randomized, Double-Blind, Placebo-Controlled Program to Evaluate the Efficacy and Safety of MK-7240 in Participants with Moderately to Severely Active Ulcerative Colitis

Project: Research

Project Details

Project Description



StatusActive
Effective start/end date24/09/24 → 23/03/27

Clinical Trial Phase

  • Phase III (a & b)